Medical Devices

Medical devices cover an array products from consumable items to innovative implants and appliances, each serving a particular application or therapeutic area. The medical devices market has seen seismic changes with regional regulations, downwards pricing pressures and advancement in technological standards, equipment and procedures. A&M supports medical device companies in addressing critical objectives with our seasoned industry operators and results-driven approach.

To help deliver sustainable value creation, we support medical device companies and investors in the following areas:

M&A Strategy, Carve-Outs & Synergy Capture
Product Innovation & Launch
Pricing & Reimbursements
Business Unit / Model Re-design
Product Margin Improvement
Sales & Marketing Effectiveness
Supply Chain Operations
R&D and Portfolio Review
Quality Control, Improvement & Compliance
Regulatory Compliance
Operating Cost & Working Capital Optimisation

We support a broad range of medical device developers, manufacturers and distributors, our experience covers the following specialist areas:

Medical Imaging
In-Vitro Diagnostics
Orthopaedic Implants & Equipment
Surgical Equipment & Supplies
Aesthetic Devices
Dental
Ophthalmology
ENT
Distributors & Wholesalers

Thought Leadership

Disruption in the ACA Market – Implications and Strategic Responses

June 11, 2025

In a recent article, A&M Healthcare Industry Group experts explore key policy changes, market dynamics, stakeholder implications and strategic actions for navigating the evolving landscape surrounding the Affordable Care Act marketplace.

Thought Leadership

The Effect of Trump’s Tariffs on the European Pharmaceutical and Biopharmaceutical Industry

June 9, 2025

As the U.S. considers imposing tariffs on European pharmaceutical imports, the ripple effects could be felt across the global healthcare landscape.

Press Releases

FORMER FEDERAL HEALTH MINISTER PROFESSOR GREG HUNT JOINS ALVAREZ & MARSAL AUSTRALIA

May 27, 2025

Alvarez & Marsal appoints The Honourable Greg Hunt as a Senior Advisor bolstering its Healthcare and Public Sector advisories in support of maximizing sustainable value for clients.

Thought Leadership

Contract Research Organisations M&A Market

March 28, 2025

Rising cost pressures, stricter regulatory demands and advancements in emerging therapeutics are intensifying competition within the industry. These dynamics are fuelling the demand for greater efficiency in development lifecycles, creating significant opportunities for outsourced providers like Contract Research Organisations (CROs).